JY
ADXN

Jeff Yass’s Addex Therapeutics ADXN Stock Holding History

Jeff Yass’s Portfolio ADXN Stock Details ADXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-754
Closed -$14.3K – 11950
2023
Q1 		$14.3K Sell
754
-2,853
-79% -$72.1K ﹤0.01% 12136
2022
Q4 		$45.4K Buy
+3,607
New +$53.3K ﹤0.01% 11446

Other funds holding ADXN

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

Jeff Yass's ADXN Position: Q2 2023 in Review

Jeff Yass sold out of Addex Therapeutics (ADXN) in Q2 2023, closing a stake of 754 shares — an estimated $14.3K sold.

Jeff Yass first reported a position in ADXN in Q4 2022 and held it in 2 quarters. The position peaked at $45.4K in Q4 2022. 3 funds tracked by Wall St. Rank hold ADXN as of Q2 2023.

  • Jeff Yass reported no remaining Addex Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Jeff Yass sold 754 Addex Therapeutics shares in Q2 2023, an estimated $14.3K.
  • Jeff Yass first reported a position in Addex Therapeutics in Q4 2022 and held it in 2 quarters.
  • Jeff Yass's Addex Therapeutics position peaked at $45.4K in Q4 2022.
  • 3 funds tracked by Wall St. Rank held Addex Therapeutics as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.